Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program

被引:62
|
作者
Albores-Saavedra, Jorge [1 ]
Batich, Kristen [2 ]
Hossain, Sarah [3 ]
Henson, Donald E. [2 ]
Schwartz, Arnold M. [4 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico
[2] George Washington Univ, Inst Canc, Off Canc Prevent & Control, Washington, DC USA
[3] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Epidemiol & Biostat, Washington, DC USA
[4] George Washington Univ, Med Ctr, Dept Pathol, Washington, DC 20037 USA
关键词
Carcinoid; Small-cell carcinoma; Neuroendocrine carcinoma; Gallbladder; Extrahepatic bile duct; PANCREATIC-POLYPEPTIDE; FOLLOW-UP; COMPLICATION;
D O I
10.1016/j.anndiagpath.2009.08.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Primary neuroendocrine tumors of the gallbladder (GB) and extrahepatic biliary ducts (EHBDs) include carcinoid tumors and small-cell carcinomas (SCCs). They are uncommon, and therefore, little is known about their demographics and clinical course. From National Cancer Institute's Surveillance, Epidemiology, and End Results program (1973-2005), we analyzed the demographics and 10-year relative survival rates of carcinoids and SCCs of the GB and EHBD according to histologic type and stage. There were 119 cases of carcinoid tumors and 54 cases of SCCs in the GB. There were 31 carcinoid tumors and 17 SCCs in the EHBD. The female/male ratios of carcinoids in the GB and EHBD were 2.4 and 1.6, respectively. The ratios for SCC in the GB and EHBD were 2.2 and 1.1, respectively. For the GB, the mean age of diagnosis for carcinoids was 64.5, and for SCC, it was 67.5. For the EHBD, the mean age was 58.2 for carcinoids and 68.4 for SCC. The 10-year survival rates were 36% for carcinoid tumors of the GB and 80% for carcinoid tumors of the EHBD. For SCC, the 10-year survival was 0% in the GB and EHBD. Carcinoid tumors and SCC of the extrahepatic biliary tree are uncommon neoplasms that differ in their demographics and biologic behavior, supporting the distinction of these 2 histopathologic types. Therefore, these tumors should be separately classified and not included in the single generic group of neuroendocrine carcinoma. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:378 / 383
页数:6
相关论文
共 47 条
  • [1] Comparative Study of Papillary Carcinomas and Conventional Adenocarcinomas of the Extrahepatic Bile Ducts. A Study of 5870 Cases from the SEER Program of the National Cancer Institute
    Albores-Saavedra, J.
    Shah, A.
    Chable-Montero, F.
    Henson, D. E.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 153A - 153A
  • [2] Comparative Study of Papillary Carcinomas and Conventional Adenocarcinomas of the Extrahepatic Bile Ducts. A Study of 5870 Cases from the SEER Program of the National Cancer Institute
    Albores-Saavedra, J.
    Shah, A.
    Chable-Montero, F.
    Henson, D. E.
    [J]. MODERN PATHOLOGY, 2012, 25 : 153A - 153A
  • [3] Carcinoids and High-Grade Neuroendocrine Carcinomas of the Ampulla of Vater A Comparative Analysis of 139 Cases From the Surveillance, Epidemiology, and End Results Program-A Population Based Study
    Albores-Saavedra, Jorge
    Hart, Alexandra
    Chable-Montero, Fredy
    Henson, Donald E.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (11) : 1692 - 1696
  • [4] Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: A Surveillance, Epidemiology, and End Results-based Study
    Aguiar Bujanda, David
    Perez Cabrera, Daniel
    Croissier Sanchez, Laura
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (12): : 493 - 500
  • [5] The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975-2004)
    Beebe-Dimmer, Jennifer L.
    Cetin, Karynsa
    Fryzek, Jon P.
    Schuetze, Scott M.
    Schwartz, Kendra
    [J]. RARE TUMORS, 2009, 1 (02)
  • [6] Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data
    Bean, Marta B.
    Liu, Yuan
    Jiang, Renjain
    Steuer, Conor Ernst
    Patel, Mihir
    McDonald, Mark William
    Higgins, Kristin Ann
    Beitler, Jonathan Jay
    Shin, Dong Moon
    Saba, Nabil F.
    [J]. ONCOLOGIST, 2019, 24 (12): : 1562 - 1569
  • [7] Comparative study of survival among small cell lung cancer patients in the US military health system and those in the surveillance, epidemiology, and end results (SEER) program
    Lin, Jie
    Kamamia, Christine
    Brown, Derek W.
    Shao, Stephanie
    McGlynn, Katherine A.
    Nations, Joel A.
    Carter, Corey A.
    Shriver, Craig D.
    Zhu, Kangmin
    [J]. ANNALS OF EPIDEMIOLOGY, 2021, 64 : 132 - 139
  • [8] The incidence and prognosis of thymic squamous cell carcinoma A Surveillance, Epidemiology, and End Results Program population-based study
    Wu, Jingyi
    Wang, Zhijun
    Jing, Caibao
    Hu, Yang
    Yang, Bing
    Hu, Yanping
    [J]. MEDICINE, 2021, 100 (15) : E25331
  • [9] Desmoplastic Small Round Cell Tumor (DSRCT): A Population-based Study from the Surveillance, Epidemiology, and End Results (SEER) Database
    Cooper, S. L.
    Armeson, K.
    Garrett-Mayer, E.
    Hudspeth, M.
    Jenrette, J.
    Camp, R.
    Streck, C. J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S147 - S147
  • [10] Subependymal Giant Cell Astrocytoma: A Surveillance, Epidemiology, and End Results Program-Based Analysis from 2004 to 2013
    Ha Son Nguyen
    Doan, Ninh B.
    Gelsomino, Michael
    Shabani, Saman
    Awad, Ahmed J.
    Best, Benjamin
    Kaushal, Mayank
    Mortazavi, Martin M.
    [J]. WORLD NEUROSURGERY, 2018, 118 : E263 - E268